These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32106310)

  • 1. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
    Karube K; Feldman AL
    Blood; 2020 Feb; 135(9):700. PubMed ID: 32106310
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL; Feldman AL
    Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C; Chen X; Chen XY; He YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-occurring rearrangements of
    Klairmont MM; Ward N
    Leuk Lymphoma; 2022 Feb; 63(2):506-508. PubMed ID: 34612143
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Pedersen MB; Hamilton-Dutoit SJ; Bendix K; Ketterling RP; Bedroske PP; Luoma IM; Sattler CA; Boddicker RL; Bennani NN; Nørgaard P; Møller MB; Steiniche T; d'Amore F; Feldman AL
    Blood; 2017 Jul; 130(4):554-557. PubMed ID: 28522440
    [No Abstract]   [Full Text] [Related]  

  • 6. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
    Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements.
    Luo DX; Li W; Ye MT; Yang Y; Tang G; You MJ
    Am J Hematol; 2020 Dec; 95(12):1625-1627. PubMed ID: 32833271
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Hapgood G; Ben-Neriah S; Mottok A; Lee DG; Robert K; Villa D; Sehn LH; Connors JM; Gascoyne RD; Feldman AL; Farinha P; Steidl C; Scott DW; Slack GW; Savage KJ
    Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
    [No Abstract]   [Full Text] [Related]  

  • 9. Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
    Aarakaki H; Karube K
    Blood; 2022 Jan; 139(3):465. PubMed ID: 35050329
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
    Zhang Y; Chen M; Yu Y; Liu X; Liu W; Jiang L; Zhang W
    J Cutan Pathol; 2022 Feb; 49(2):187-190. PubMed ID: 34622970
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Wang M; Kibbi N; Ring N; Siddon A; Foss F; Totonchy M
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31570354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL; Dao LN; McPhail ED; Jaffe ES; Said J; Swerdlow SH; Sattler CA; Ketterling RP; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Gibson SE; Ondrejka SL; Nicolae A; Macon WR; Dasari S; Parrilla Castellar E; Feldman AL
    Am J Surg Pathol; 2016 Jan; 40(1):36-43. PubMed ID: 26379151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
    Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
    Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with
    Luchtel RA; Dasari S; Oishi N; Pedersen MB; Hu G; Rech KL; Ketterling RP; Sidhu J; Wang X; Katoh R; Dogan A; Kip NS; Cunningham JM; Sun Z; Baheti S; Porcher JC; Said JW; Jiang L; Hamilton-Dutoit SJ; Møller MB; Nørgaard P; Bennani NN; Chng WJ; Huang G; Link BK; Facchetti F; Cerhan JR; d'Amore F; Ansell SM; Feldman AL
    Blood; 2018 Sep; 132(13):1386-1398. PubMed ID: 30093402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A; Feldman AL; Ketterling RP; Dasari S; Rech KL; McPhail ED; Kurtin PJ; Shi M
    Am J Surg Pathol; 2021 Apr; 45(4):550-557. PubMed ID: 33165091
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Savage KJ; Slack GW
    Haematologica; 2023 Jun; 108(6):1463-1467. PubMed ID: 36453106
    [No Abstract]   [Full Text] [Related]  

  • 17. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
    Diaz de la Pinta FJ; Machan S; Manso Alonso R; Carvajal N; Nieves Salgado R; Piris MA; Rodriguez-Pinilla SM
    Histopathology; 2022 Jan; 80(2):446-449. PubMed ID: 34252219
    [No Abstract]   [Full Text] [Related]  

  • 18. Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
    Chapman J; Vega F
    Histopathology; 2017 Jun; 70(7):1173-1175. PubMed ID: 28042680
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
    Anderson J; Putnam E; Liu W; Menon MP
    Int J Lab Hematol; 2022 Feb; 44(1):67-68. PubMed ID: 34019742
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement.
    Fratoni S; Trawinska MM; Capalbo A; Bernardini L; Fabbretti M; Martini M; Niscola P; Zhao XF
    Virchows Arch; 2022 Dec; 481(6):975-979. PubMed ID: 35879438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.